Michael Gallagher - Publications

Affiliations: 
Whitehead Institute (MIT), Cambridge, MA, United States 

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Krzisch M, Yuan B, Chen W, Osaki T, Fu D, Garrett-Engele CM, Svoboda DS, Andrykovich KR, Gallagher MD, Sur M, Jaenisch R. The A53T mutation in α-synuclein enhances pro-inflammatory activation in human microglia upon inflammatory stimulus. Biological Psychiatry. PMID 39029776 DOI: 10.1016/j.biopsych.2024.07.011  0.49
2023 Diaz-Ortiz ME, Jain N, Gallagher MD, Posavi M, Unger TL, Chen-Plotkin AS. Testing for Allele-specific Expression from Human Brain Samples. Bio-Protocol. 13: e4832. PMID 37817908 DOI: 10.21769/BioProtoc.4832  0.741
2022 Diaz-Ortiz ME, Seo Y, Posavi M, Carceles Cordon M, Clark E, Jain N, Charan R, Gallagher MD, Unger TL, Amari N, Skrinak RT, Davila-Rivera R, Brody EM, Han N, Zack R, et al. GPNMB confers risk for Parkinson's disease through interaction with α-synuclein. Science (New York, N.Y.). 377: eabk0637. PMID 35981040 DOI: 10.1126/science.abk0637  0.473
2018 Gallagher MD, Chen-Plotkin AS. The Post-GWAS Era: From Association to Function. American Journal of Human Genetics. 102: 717-730. PMID 29727686 DOI: 10.1016/j.ajhg.2018.04.002  0.637
2017 Gallagher MD, Posavi M, Huang P, Unger TL, Berlyand Y, Gruenewald AL, Chesi A, Manduchi E, Wells AD, Grant SFA, Blobel GA, Brown CD, Chen-Plotkin AS. A Dementia-Associated Risk Variant near TMEM106B Alters Chromatin Architecture and Gene Expression. American Journal of Human Genetics. PMID 29056226 DOI: 10.1016/J.Ajhg.2017.09.004  0.688
2017 Cooper CA, Jain N, Gallagher MD, Weintraub D, Xie SX, Berlyand Y, Espay AJ, Quinn J, Edwards KL, Montine T, Van Deerlin VM, Trojanowski J, Zabetian CP, Chen-Plotkin AS. Common variant rs356182 near SNCA defines a Parkinson's disease endophenotype. Annals of Clinical and Translational Neurology. 4: 15-25. PMID 28078311 DOI: 10.1002/Acn3.371  0.732
2015 Swanson CR, Li K, Unger TL, Gallagher MD, Van Deerlin VM, Agarwal P, Leverenz J, Roberts J, Samii A, Gross RG, Hurtig H, Rick J, Weintraub D, Trojanowski JQ, Zabetian C, et al. Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 805-12. PMID 25227208 DOI: 10.1002/Mds.26022  0.79
2014 Gallagher MD, Suh E, Grossman M, Elman L, McCluskey L, Van Swieten JC, Al-Sarraj S, Neumann M, Gelpi E, Ghetti B, Rohrer JD, Halliday G, Van Broeckhoven C, Seilhean D, Shaw PJ, et al. TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. Acta Neuropathologica. 127: 407-18. PMID 24442578 DOI: 10.1007/S00401-013-1239-X  0.67
2012 Chen-Plotkin AS, Unger TL, Gallagher MD, Bill E, Kwong LK, Volpicelli-Daley L, Busch JI, Akle S, Grossman M, Van Deerlin V, Trojanowski JQ, Lee VM. TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 11213-27. PMID 22895706 DOI: 10.1523/Jneurosci.0521-12.2012  0.723
Show low-probability matches.